Warfarin in vulnerable older adults with atrial fibrillation.
Publication
, Journal Article
Gharacholou, SM; Becker, RC
Published in: J Thromb Thrombolysis
May 2009
Duke Scholars
Published In
J Thromb Thrombolysis
DOI
EISSN
1573-742X
Publication Date
May 2009
Volume
27
Issue
4
Start / End Page
461 / 464
Location
Netherlands
Related Subject Headings
- Warfarin
- Thrombosis
- Humans
- Cardiovascular System & Hematology
- Atrial Fibrillation
- Aged
- Age Factors
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Gharacholou, S. M., & Becker, R. C. (2009). Warfarin in vulnerable older adults with atrial fibrillation. J Thromb Thrombolysis, 27(4), 461–464. https://doi.org/10.1007/s11239-009-0344-0
Gharacholou, S Michael, and Richard C. Becker. “Warfarin in vulnerable older adults with atrial fibrillation.” J Thromb Thrombolysis 27, no. 4 (May 2009): 461–64. https://doi.org/10.1007/s11239-009-0344-0.
Gharacholou SM, Becker RC. Warfarin in vulnerable older adults with atrial fibrillation. J Thromb Thrombolysis. 2009 May;27(4):461–4.
Gharacholou, S. Michael, and Richard C. Becker. “Warfarin in vulnerable older adults with atrial fibrillation.” J Thromb Thrombolysis, vol. 27, no. 4, May 2009, pp. 461–64. Pubmed, doi:10.1007/s11239-009-0344-0.
Gharacholou SM, Becker RC. Warfarin in vulnerable older adults with atrial fibrillation. J Thromb Thrombolysis. 2009 May;27(4):461–464.
Published In
J Thromb Thrombolysis
DOI
EISSN
1573-742X
Publication Date
May 2009
Volume
27
Issue
4
Start / End Page
461 / 464
Location
Netherlands
Related Subject Headings
- Warfarin
- Thrombosis
- Humans
- Cardiovascular System & Hematology
- Atrial Fibrillation
- Aged
- Age Factors
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences